Goldman Sachs’s Sanaby Health Acquisition Corp. I Class A Common Stock SANB Stock Holding History
Bought
Maintained
Sold
Other funds holding SANB
SCM
HCM
SC
MMA
PAMP
SCM
AC
AIMCA
Goldman Sachs's SANB Position: Q3 2022 in Review
Goldman Sachs sold out of Sanaby Health Acquisition Corp. I Class A Common Stock (SANB) in Q3 2022, closing a stake of 19,289 shares — an estimated $194K sold.
Goldman Sachs first reported a position in SANB in Q1 2022 and held it in 2 quarters. The position peaked at $222K in Q1 2022. 61 funds tracked by Wall St. Rank hold SANB as of Q3 2022.
- Goldman Sachs reported no remaining Sanaby Health Acquisition Corp. I Class A Common Stock position as of Q3 2022 after selling out during the quarter.
- Goldman Sachs sold 19,289 Sanaby Health Acquisition Corp. I Class A Common Stock shares in Q3 2022, an estimated $194K.
- Goldman Sachs first reported a position in Sanaby Health Acquisition Corp. I Class A Common Stock in Q1 2022 and held it in 2 quarters.
- Goldman Sachs's Sanaby Health Acquisition Corp. I Class A Common Stock position peaked at $222K in Q1 2022.
- 61 funds tracked by Wall St. Rank held Sanaby Health Acquisition Corp. I Class A Common Stock as of Q3 2022.
Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.